Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03020719 · ClinicalTrials.gov registry record · Phase 2
The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis
A Phase 2 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT03020719 is a Phase 2 study that has completed, run by University of Minnesota. The registered enrollment target is 60 participants.
The verdict
NCT03020719, a Phase 2 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this randomized, placebo-controlled (Phase II) study will be to further evaluate the effects of oral glutathione on growth in children with CF.
Interventions
- DRUG Placebo
- DRUG Oral Glutathione
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2018-12-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03020719
The ClinicalTrials.gov registry entry for NCT03020719 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03020719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03020719 about?
NCT03020719 is a clinical study titled "The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis". The purpose of this randomized, placebo-controlled (Phase II) study will be to further evaluate the effects of oral glutathione on growth in children with CF.
What is the current status of trial NCT03020719?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2017-06-14. Estimated completion is 2018-12-12.
What interventions are being tested in trial NCT03020719?
The interventions under investigation include: Placebo (DRUG), Oral Glutathione (DRUG).
Who is sponsoring clinical trial NCT03020719?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.